LAMEA Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Application (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Endocrine, Immunology, Nutritional & Metabolic Disease, Cardiology, Mental/Behavioral Disorder, Pediatrics-specific Testing, and Others), By Technology, By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa Laboratory Developed Tests Market would witness market growth of 8.1% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Laboratory Developed Tests Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $364.9 million by 2031. The Argentina market is showcasing a CAGR of 8.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 7.8% during (2024 - 2031).

Liquid biopsy assays, which analyze circulating biomarkers such as circulating tumor DNA (ctDNA), exosomes, and circulating tumor cells (CTCs), represent a burgeoning area of LDT development. Laboratories are developing liquid biopsy tests for cancer detection, monitoring, and treatment response assessment, offering minimally invasive alternatives to traditional tissue biopsies.

Innovation is a driving force in the laboratory developed tests market, catalyzing technological advancements, methodology, and clinical application advancements. Laboratories, research institutions, and industry stakeholders are pioneering new approaches to diagnostic testing, biomarker discovery, and therapeutic intervention, leading to diverse innovative LDTs.

The high prevalence of NCDs, such as cardiovascular diseases, diabetes, cancer, and respiratory disorders in Saudi Arabia, leads to a greater demand for diagnostic testing. As the burden of NCDs continues to rise, there is a corresponding increase in the utilization of LDTs in clinical practice, driving market expansion and revenue growth in the diagnostics sector. Non-communicable diseases (NCDs) cause 68% of Saudi Arabia’s deaths, according to the International Trade Administration (ITA). Adults with diabetes account for about 18% of the population, whereas obesity rates exceed 40%. Furthermore, The aging population in Brazil necessitates a greater emphasis on preventive healthcare services, promoting healthy aging, and preventing age-related complications. The aging population in Brazil necessitates a greater emphasis on preventive healthcare services, promoting healthy aging, and preventing age-related complications.

Free Valuable Insights: The Worldwide Laboratory Developed Tests Market is Projected to reach USD 20.3 Billion by 2031, at a CAGR of 6.9%

Based on Application, the market is segmented into Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Endocrine, Immunology, Nutritional & Metabolic Disease, Cardiology, Mental/Behavioral Disorder, Pediatrics-specific Testing, and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Immunoassays, Hematology & Coagulation, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

 

List of Key Companies Profiled

• Neogenomics, Inc.
• Guardant Health, Inc.
• Qiagen N.V
• Quest Diagnostics Incorporated
• Abbott Laboratories
• Siemens Healthineers AG (Siemens AG)
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• F.Hoffmann-La Roche Ltd.
• Eurofins Scientific SE

LAMEA Laboratory Developed Tests Market Report Segmentation

By Application

• Oncology
• Genetic Disorders/Inherited Disease
• Infectious & Parasitic Diseases
• Endocrine
• Immunology
• Nutritional & Metabolic Disease
• Cardiology
• Mental/Behavioral Disorder
• Pediatrics-specific Testing
• Others

By Technology

• Molecular Diagnostics
• Immunoassays
• Hematology & Coagulation
• Microbiology
• Clinical Chemistry
• Histology/Cytology
• Flow Cytometry
• Mass Spectroscopy
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Laboratory Developed Tests Market, by Application
1.4.2 LAMEA Laboratory Developed Tests Market, by Technology
1.4.3 LAMEA Laboratory Developed Tests Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Laboratory Developed Tests Market.

Chapter 5. LAMEA Laboratory Developed Tests Market by Application
5.1 LAMEA Oncology Market by Country
5.2 LAMEA Genetic Disorders/Inherited Disease Market by Country
5.3 LAMEA Infectious & Parasitic Diseases Market by Country
5.4 LAMEA Endocrine Market by Country
5.5 LAMEA Immunology Market by Country
5.6 LAMEA Nutritional & Metabolic Disease Market by Country
5.7 LAMEA Cardiology Market by Country
5.8 LAMEA Mental/Behavioral Disorder Market by Country
5.9 LAMEA Pediatrics-specific Testing Market by Country
5.1 LAMEA Others Market by Country

Chapter 6. LAMEA Laboratory Developed Tests Market by Technology
6.1 LAMEA Molecular Diagnostics Market by Country
6.2 LAMEA Immunoassays Market by Country
6.3 LAMEA Hematology & Coagulation Market by Country
6.4 LAMEA Microbiology Market by Country
6.5 LAMEA Clinical Chemistry Market by Country
6.6 LAMEA Histology/Cytology Market by Country
6.7 LAMEA Flow Cytometry Market by Country
6.8 LAMEA Mass Spectroscopy Market by Country
6.9 LAMEA Others Market by Country

Chapter 7. LAMEA Laboratory Developed Tests Market by Country
7.1 Brazil Laboratory Developed Tests Market
7.1.1 Brazil Laboratory Developed Tests Market by Application
7.1.2 Brazil Laboratory Developed Tests Market by Technology
7.2 Argentina Laboratory Developed Tests Market
7.2.1 Argentina Laboratory Developed Tests Market by Application
7.2.2 Argentina Laboratory Developed Tests Market by Technology
7.3 UAE Laboratory Developed Tests Market
7.3.1 UAE Laboratory Developed Tests Market by Application
7.3.2 UAE Laboratory Developed Tests Market by Technology
7.4 Saudi Arabia Laboratory Developed Tests Market
7.4.1 Saudi Arabia Laboratory Developed Tests Market by Application
7.4.2 Saudi Arabia Laboratory Developed Tests Market by Technology
7.5 South Africa Laboratory Developed Tests Market
7.5.1 South Africa Laboratory Developed Tests Market by Application
7.5.2 South Africa Laboratory Developed Tests Market by Technology
7.6 Nigeria Laboratory Developed Tests Market
7.6.1 Nigeria Laboratory Developed Tests Market by Application
7.6.2 Nigeria Laboratory Developed Tests Market by Technology
7.7 Rest of LAMEA Laboratory Developed Tests Market
7.7.1 Rest of LAMEA Laboratory Developed Tests Market by Application
7.7.2 Rest of LAMEA Laboratory Developed Tests Market by Technology

Chapter 8. Company Profiles
8.1 Neogenomics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Guardant Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Quest Diagnostics Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.4.5 SWOT Analysis
8.5 Abbott Laboratories
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segment and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bio-Rad laboratories, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Eurofins Scientific SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis

TABLE 1 LAMEA Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 4 LAMEA Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 5 LAMEA Oncology Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Oncology Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
TABLE 10 LAMEA Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
TABLE 11 LAMEA Endocrine Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Endocrine Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA Immunology Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA Immunology Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Cardiology Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Cardiology Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
TABLE 22 LAMEA Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
TABLE 23 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 24 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 25 LAMEA Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 26 LAMEA Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 27 LAMEA Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Immunoassays Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Immunoassays Market by Country, 2024 - 2031, USD Million
TABLE 31 LAMEA Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
TABLE 32 LAMEA Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
TABLE 33 LAMEA Microbiology Market by Country, 2020 - 2023, USD Million
TABLE 34 LAMEA Microbiology Market by Country, 2024 - 2031, USD Million
TABLE 35 LAMEA Clinical Chemistry Market by Country, 2020 - 2023, USD Million
TABLE 36 LAMEA Clinical Chemistry Market by Country, 2024 - 2031, USD Million
TABLE 37 LAMEA Histology/Cytology Market by Country, 2020 - 2023, USD Million
TABLE 38 LAMEA Histology/Cytology Market by Country, 2024 - 2031, USD Million
TABLE 39 LAMEA Flow Cytometry Market by Country, 2020 - 2023, USD Million
TABLE 40 LAMEA Flow Cytometry Market by Country, 2024 - 2031, USD Million
TABLE 41 LAMEA Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
TABLE 42 LAMEA Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
TABLE 43 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 44 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 45 LAMEA Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
TABLE 46 LAMEA Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
TABLE 47 Brazil Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 48 Brazil Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 49 Brazil Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 50 Brazil Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 51 Brazil Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 52 Brazil Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 53 Argentina Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 54 Argentina Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 55 Argentina Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 56 Argentina Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 57 Argentina Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 58 Argentina Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 59 UAE Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 60 UAE Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 61 UAE Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 62 UAE Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 63 UAE Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 64 UAE Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 65 Saudi Arabia Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 66 Saudi Arabia Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 67 Saudi Arabia Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 68 Saudi Arabia Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 69 Saudi Arabia Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 70 Saudi Arabia Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 71 South Africa Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 72 South Africa Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 73 South Africa Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 74 South Africa Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 75 South Africa Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 76 South Africa Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 77 Nigeria Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 78 Nigeria Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 79 Nigeria Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 80 Nigeria Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 81 Nigeria Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 82 Nigeria Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 83 Rest of LAMEA Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 84 Rest of LAMEA Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 85 Rest of LAMEA Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 86 Rest of LAMEA Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 87 Rest of LAMEA Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 88 Rest of LAMEA Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 89 Key Information – neogenomics, inc.
TABLE 90 Key Information – GUARDANT HEALTH, INC.
TABLE 91 Key Information – Qiagen N.V.
TABLE 92 Key information – Quest Diagnostics Incorporated
TABLE 93 Key Information – Abbott Laboratories
TABLE 94 Key Information – Siemens Healthineers AG
TABLE 95 key information – Illumina, Inc.
TABLE 96 Key Information – Bio-Rad Laboratories, Inc.
TABLE 97 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 98 Key Information – Eurofins Scientific SE

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Laboratory Developed Tests Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Laboratory Developed Tests Market
FIG 4 Porter’s Five Forces Analysis – Laboratory Developed Tests Market
FIG 5 LAMEA Laboratory Developed Tests Market share by Application, 2023
FIG 6 LAMEA Laboratory Developed Tests Market share by Application, 2031
FIG 7 LAMEA Laboratory Developed Tests Market by Application, 2020 - 2031, USD Million
FIG 8 LAMEA Laboratory Developed Tests Market share by Technology, 2023
FIG 9 LAMEA Laboratory Developed Tests Market share by Technology, 2031
FIG 10 LAMEA Laboratory Developed Tests Market by Technology, 2020 - 2031, USD Million
FIG 11 LAMEA Laboratory Developed Tests Market share by Country, 2023
FIG 12 LAMEA Laboratory Developed Tests Market share by Country, 2031
FIG 13 LAMEA Laboratory Developed Tests Market by Country, 2020 - 2031, USD Million
FIG 14 Swot Analysis: Neogenomics, Inc.
FIG 15 Swot Analysis: Guardant Health, Inc.
FIG 16 Recent strategies and developments: Qiagen N.V.
FIG 17 Swot Analysis: Qiagen N.V.
FIG 18 SWOT Analysis: Quest Diagnostics Incorporated
FIG 19 SWOT Analysis: Abbott Laboratories
FIG 20 SWOT Analysis: Siemens Healthineers AG
FIG 21 Swot Analysis: Illumina, Inc.
FIG 22 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 23 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 24 SWOT Analysis: Eurofins Scientific SEs